Do we perform a Hemoglobin A1c (HbA1c) test on a 22-year-old female with a Body Mass Index (BMI) of 36?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HbA1c Testing in a 22-Year-Old Female with BMI of 36

Yes, HbA1c testing is recommended for this 22-year-old female with a BMI of 36 as she meets the criteria for diabetes screening due to her obesity risk factor. 1, 2

Rationale for Testing

The American Diabetes Association (ADA) guidelines provide clear recommendations for diabetes screening in individuals with risk factors:

  • BMI ≥25 kg/m² is considered a significant risk factor for diabetes 1
  • This patient has a BMI of 36, which falls into the obesity category and significantly increases her diabetes risk
  • Obesity is an independent indication for diabetes screening regardless of age 2

Testing Approach

Recommended Test

  • HbA1c is appropriate for initial screening as it:
    • Does not require fasting
    • Reflects average glycemia over the preceding 2-3 months
    • Has greater preanalytical stability than plasma glucose measurements 1
    • Should be performed using a method that is NGSP certified and standardized to the DCCT assay 1

Interpretation of Results

  • Normal: <5.7%
  • Prediabetes: 5.7-6.4%
  • Diabetes: ≥6.5% 2

Confirmatory Testing

  • In the absence of unequivocal hyperglycemia, diagnosis requires:
    • Two abnormal test results from the same sample (e.g., both FPG and HbA1c)
    • OR two abnormal results from samples obtained on different days 1

Important Considerations

Potential Limitations of HbA1c

  • HbA1c may not accurately reflect glycemia in conditions affecting red blood cell turnover:

    • Hemoglobinopathies
    • Pregnancy (second and third trimesters)
    • Recent blood loss or transfusion
    • Erythropoietin therapy 1
  • If there's marked discrepancy between measured HbA1c and plasma glucose levels, consider:

    • Possible HbA1c assay interference
    • Using an assay without interference
    • Using plasma blood glucose criteria instead 1

Alternative Testing Options

If HbA1c is not appropriate or available:

  • Fasting plasma glucose (FPG ≥126 mg/dL indicates diabetes)
  • 2-hour plasma glucose during OGTT (≥200 mg/dL indicates diabetes) 1

Follow-up Testing

If initial results are normal:

  • Repeat testing every 3 years 2

If prediabetes is diagnosed:

  • Annual testing is recommended 1, 2

If diabetes is diagnosed:

  • Test HbA1c at least twice per year in patients meeting treatment goals
  • Test quarterly in patients whose therapy has changed or who are not meeting glycemic goals 1

Clinical Pearls

  • Young adults with obesity are at increased risk for early-onset type 2 diabetes
  • Early detection of prediabetes allows for lifestyle interventions that may prevent or delay progression to diabetes
  • Point-of-care A1c testing should not be used for diagnosis unless FDA-cleared for this purpose 1
  • The relationship between HbA1c and mean glucose can vary between individuals, so clinical context is important when interpreting results 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diabetes Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.